Wang [10] et al. found that lenalidomide promoted the expansion of CD8 + CAR-T cells, increased the formation of immune synapses between CAR-T cells and tumor cells, significantly inhibited tumor growth, and extended CAR-T cells’ persistence and survival in tumor-bearing mice (p < 0.01). Here, CD8A is linked to neoplasm.